38 resultados para Quadridentate Snns Ligands


Relevância:

10.00% 10.00%

Publicador:

Resumo:

J Biol Inorg Chem (2007) 12:353–366 DOI 10.1007/s00775-006-0191-9

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Acc. Chem. Res., 2006, 39 (10), pp 788–796 DOI: 10.1021/ar050104k

Relevância:

10.00% 10.00%

Publicador:

Resumo:

J Biol Inorg Chem (2006) 11: 548–558 DOI 10.1007/s00775-006-0104-y

Relevância:

10.00% 10.00%

Publicador:

Resumo:

J Biol Inorg Chem (2006) 11: 307–315 DOI 10.1007/s00775-005-0077-2

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Eur. J. Biochem. 270, 3904–3915 (2003) doi:10.1046/j.1432-1033.2003.03772.x

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação para obtenção do Grau de Doutor em Bioquímica – Ramo Bioquímica Estrutural

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação apresentada para a obtenção do Grau de Doutor em Química Sustentável, especialidade de Química-Física Inorgânica, pela Universidade Nova de Lisboa, Faculdade de Ciências e Tecnologia

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação apresentada para a obtenção do Grau de Mestre em Biotecnologia, pela Universidade Nova de Lisboa, Faculdade de Ciências e Tecnologia

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertation presented to obtain the Ph.D degree in Biochemistry

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação para obtenção do Grau de Mestre em Engenharia Química e Bioquímica

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação para a obtenção do grau de Mestre em Genética Molecular e Biomedicina

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Dissertação para obtenção do Grau de Doutor em Bioengenharia (MIT-Portugal)

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Fundação para a Ciência e Tecnologia - SFRH/BD/48804/2008 and the project PTDC/BI/65383/2006 assigned to Prof. Cecíla Roque and also to Associate Laboratory REQUIMTE (Pest-C/EQB/LA0006/2011)

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Bradykinin is a peptide of the kinin group, involved in a number of receptor-mediated physiological actions, including inflammation and vasodilation, as well as neuromodulation, neuroprotection and promotion of neurogenesis. Bradykinin is the main ligand of the B2 receptor- the main kinin receptor- which is involved in the cardiac and renal protective effects of kinins in diseases. Antibodies have been considered for a long time as promising therapeutic agents in various fields, especially cancer-related ones. Aptamers, on the other hand, have proven to be an excellent alterative, since they have similar properties to those of monoclonal antibodies, such a high-specificity of recognition and high-affinity binding. Plus, they are developed using in vitro selection procedures and can be reproduced by enzymatic reactions. SELEX is a powerful tool for the development of both DNA and RNA aptamers. The main goal of this project was to design a method to select aptamers against bradykinin using capillary electrophoresis alongside the SELEX technique. The selection was done by comparing the aptamers’ (ssDNA-target complex) electrophoretic mobility with that of the ssDNA and the target, which allowed us to define an appropriate collection window that took into consideration the analytes’ detection time, thus enabling the collection of the desired oligonucleotides. After two selection rounds, the collected pool was sequenced, the affinity was measured and the aptamers’ secondary structure was predicted. We concluded that with only two selection cycles, the original DNA library’s bulk affinity grew around 0.4%. The structural characterization of the aptamers, performed with the aid of the Mfold software, revealed that there are many repetitive motifs amongst them, indicating that the selection process was successful. We have obtained 16 sequences of candidate aptamers as bradykinin ligands of similar sequences and secondary structures whose biological activity should be analyzed after synthesis; mainly in regard to their role as bradykinin inhibitors.